Nanci Pittman
Overview
Explore the profile of Nanci Pittman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen X, Carvalho B, Sinha A, Pittman N, Benkov K, Lai J, et al.
Cell Mol Gastroenterol Hepatol
. 2025 Mar;
:101488.
PMID: 40024536
No abstract available.
2.
Lozano-Ojalvo D, Chen X, Kazmi W, Menchen-Martinez D, Perez-Rodriguez L, Fernandes-Braga W, et al.
J Allergy Clin Immunol
. 2024 Oct;
155(3):909-922.
PMID: 39389123
Background: IgE-mediated food allergy and eosinophilic esophagitis (EoE) are diseases commonly triggered by milk. Milk-responsive CD4 T cells producing type 2 cytokines are present in both diseases, yet the clinical...
3.
Dolinger M, Aronskyy I, Kellar A, Spencer E, Pittman N, Dubinsky M
J Crohns Colitis
. 2023 Dec;
18(7):1002-1011.
PMID: 38141229
Background And Aims: STRIDE-II recommends early biomarker targets for treatment optimization to achieve treat-to-target [T2T] endoscopic remission [ER] in Crohn's disease [CD]. The predictive capabilities of intestinal ultrasound [IUS] for...
4.
Spencer E, Bergstein S, Dolinger M, Pittman N, Kellar A, Dunkin D, et al.
Inflamm Bowel Dis
. 2023 Dec;
30(11):2057-2063.
PMID: 38134405
Background: Upadacitinib (UPA) is a novel selective JAK inhibitor approved for adults with ulcerative colitis (UC) and with positive phase 3 data for Crohn's disease (CD). Pediatric off-label use is...
5.
Dolinger M, Aronskyy I, Kellar A, Gao M, Spencer E, Pittman N, et al.
Am J Gastroenterol
. 2023 Dec;
119(5):930-936.
PMID: 38131626
Introduction: High rates of screen failure for the minimum Simple Endoscopic Score for Crohn's Disease (SES-CD) plague Crohn's disease (CD) clinical trials. We aimed to determine the accuracy of segmental...
6.
Chen X, Lai J, Song Y, Yang N, Gnjatic S, Gillespie V, et al.
Front Med (Lausanne)
. 2021 Dec;
8:782859.
PMID: 34926527
TNF-α has a major role in the pathogenesis of Crohn's disease (CD). In contrast, GM-CSF may be beneficial for its anti-inflammatory role in a subset of patients with CD with...
7.
Spencer E, Klang E, Dolinger M, Pittman N, Dubinsky M
Inflamm Bowel Dis
. 2021 Aug;
27(11):1862-1864.
PMID: 34427638
No abstract available.
8.
Dolinger M, Person H, Smith R, Jarchin L, Pittman N, Dubinsky M, et al.
J Pediatr Gastroenterol Nutr
. 2020 May;
71(2):153-155.
PMID: 32452979
Coronavirus disease 2019 (COVID-19) may lead to a severe inflammatory response referred to as a cytokine storm. We describe a case of severe COVID-19 infection in a recently diagnosed pediatric...
9.
Jossen J, Kiernan B, Pittman N, Dubinsky M
J Pediatr Gastroenterol Nutr
. 2019 Nov;
70(3):304-309.
PMID: 31738290
Background: Vedolizumab (VDZ) is effective for treating both adult and pediatric onset inflammatory bowel disease (IBD). Clinical outcomes, however, have been reported to be superior in patients naïve to anti-tumor...
10.
Carlsen K, Phan B, Pittman N, Benkov K, Dubinsky M, Keefer L
Gastroenterol Nurs
. 2019 Aug;
42(4):342-350.
PMID: 31365424
Parents of teens with inflammatory bowel disease must prepare their children for independent disease self-management. This study characterizes the stressors and coping strategies adopted among parents of teens with inflammatory...